Programs

  • Program 1 [2025]

    COG RESEARCH FOUNDATION, LLC PROVIDES ADMINISTRATIVE, AS WELL AS STATISTICAL AND DATA MANAGEMENT SUPPORT FOR THE CHILDREN'S ONCOLOGY GROUP (COG). THE COG, A CLINICAL TRIALS GROUP SUPPORTED BY THE NATIONAL CANCER INSTITUTE, IS THE WORLD'S LARGEST ORGANIZATION DEVOTED EXCLUSIVELY TO CHILDHOOD AND ADOLESCENT CANCER RESEARCH. COG BRINGS TOGETHER MORE THAN 10,000 EXPERTS IN CHILDHOOD CANCER AT MORE THAN 200 INSTITUTIONS. THEY SUPPORT CLINICAL RESEARCH TRIALS THAT STUDY AND DETERMINE THE UNDERLYING BIOLOGY OF CHILDHOOD CANCERS, EMERGING TREATMENTS, SUPPORTIVE CARE, AND SURVIVORSHIP, AND CARE FOR 80-90% OF THE 13,500 CHILDREN AND ADOLESCENTS DIAGNOSED WITH CANCER EACH YEAR.COG IS STRUCTURED TO MAXIMIZE EFFICIENCY, PROMOTE COLLABORATION, AND RETAIN THE FLEXIBILITY TO FOCUS RESOURCES ON THE MOST PROMISING SCIENTIFIC ADVANCES. EXTENSIVE COLLABORATION AND INTEGRATION ARE FOUND THROUGHOUT COG'S ORGANIZATION. THE CHILDREN'S ONCOLOGY GROUP HAS OVER 50 ACTIVE CLINICAL TRIALS OPEN AT ANY GIVEN TIME. THESE TRIALS INCLUDE FRONT-LINE TREATMENT FOR MANY TYPES OF CHILDHOOD CANCERS, STUDIES AIMED AT DETERMINING THE UNDERLYING BIOLOGY OF THESE DISEASES, AND TRIALS INVOLVING NEW AND EMERGING TREATMENTS, SUPPORTIVE CARE, AND SURVIVORSHIP. THE CHILDREN'S ONCOLOGY GROUP RESEARCH HAS TURNED CHILDREN'S CANCER FROM A VIRTUALLY INCURABLE DISEASE 50 YEARS AGO TO ONE WITH A COMBINED 5-YEAR SURVIVAL RATE OF 86% TODAY. OUR GOAL IS TO CURE ALL CHILDREN AND ADOLESCENTS WITH CANCER, REDUCE THE SHORT AND LONG-TERM COMPLICATIONS OF CANCER TREATMENTS, AND DETERMINE THE CAUSES AND FIND WAYS TO PREVENT CHILDHOOD CANCER.
    Geographies
    Not indicated
    Dates
    Jun 1, 2024 – May 31, 2025
    Source
    990
    No causes provided
    No populations provided
    –
    $1.2M